Illumina, Inc. (ILMN) stock
ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3016% above fair value
$207.01−2.54 (-1.21%)
Close on Nov 13, 2026Market cap $31.30BP/E 35.5Yield –
Illumina ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Illumina's ebitda for the twelve months ending Dec 28, 2025 was $1.08B. For fiscal 2025 it was $1.08B. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $1.17B in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $1.08B | – |
| FY2024 | Dec 29, 2024 | -$479.00M | – |
| FY2023 | Dec 31, 2023 | -$637.00M | – |
| FY2022 | Jan 1, 2023 | -$3.79B | -3057.0% |
| FY2021 | Jan 2, 2022 | $128.00M | -83.3% |
| FY2020 | Jan 3, 2021 | $767.00M | -34.6% |
| FY2019 | Dec 29, 2019 | $1.17B | +10.5% |
| FY2018 | Dec 30, 2018 | $1.06B | +39.4% |
| FY2017 | Dec 31, 2017 | $762.00M | +4.7% |
| FY2016 | Jan 1, 2017 | $728.00M | -1.6% |
| FY2015 | Jan 3, 2016 | $740.00M | +18.0% |
| FY2014 | Dec 28, 2014 | $627.29M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 28, 2025 | $267.00M | +8.5% |
| Q3 FY2025 | Sep 28, 2025 | $294.00M | -63.7% |
| Q2 FY2025 | Jun 29, 2025 | $282.00M | – |
| Q1 FY2025 | Mar 30, 2025 | $233.00M | – |
| Q4 FY2024 | Dec 29, 2024 | $246.00M | +89.2% |
| Q3 FY2024 | Sep 29, 2024 | $811.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.53B | -937.2% |
| Q1 FY2024 | Mar 31, 2024 | -$3.00M | -101.4% |
| Q4 FY2021 | Jan 2, 2022 | $130.00M | – |
| Q3 FY2021 | Oct 3, 2021 | -$480.00M | – |
| Q4 FY2020 | Jan 3, 2021 | $183.00M | – |
| Q3 FY2020 | Sep 27, 2020 | $208.00M | – |
See a number that looks wrong?